Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B6 vs Cabergoline for Lactation Inhibition
NCT05024422Completed
- Sponsor
- Emek Medical Center
- Start
- Dec 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pyridoxine in Agalactia (2 arms), sponsored by Emek Medical Center. Primary endpoints: Lactation suppression at 7 days, Reduction of congestion at 14 days and 2 more. Started Dec 2021; status: completed.
02
Drugs
pyridoxine
03
Conditions
Agalactia
Beyond the preview
Go deeper on NCT05024422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05024422.